GENSIGHT BIOLOGICS Stock Over 14% Down So Far Today
GENSIGHT BIOLOGICS, a Paris-based biotech company specializing in the development of therapies for mitochondrial and neurodegenerative disorders, faced a significant dip in its shares on Thursday morning. After five consecutive days of losses, the shares plummeted 14.02% to EUR0.56 as of 12:05 EST. The CAC 40 index_ also marked a decreased by 0.98% to EUR7,241.12,…